Nyhet -

En ny Generation av Cell-Biosensorer för cancer-forskning

Läs artikeln i det senaste numret av  IPT (Innovations in Pharmaceutical technologies) om nya generationens cell-biosensorer som möjliggör studier  av molekylära interaktioner direkt på celler och på så sätt indikerar rätt läkemedelskandidater i ett tidigare skede inför bland annat cancer-forskning. Att få fram en bra biologiskt anpassad modell som denna med hjälp av en cell-biosensor minskar kostnaderna och tidsskalan drastiskt vid utvecklingen av morgondagens läkemedel.

Relaterade länkar

Ämnen

  • Vetenskap, teknik

Kategorier

  • attana cell 200
  • ny generation
  • ipt
  • miriam dwek
  • cell-biosensor
  • teodor aastrup
  • label free
  • quartz crystal microbalance
  • university of westminster

Relaterat innehåll

  • Biosensor- Attana Cell 200, label free, real time kinetics on cells

    Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

  • Find out: Why bridge the existing gap between biochemical and cell based assays?

    One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

  • Attana in Swedish Life Sciences

    Swedes are well known to be innovative and building successful global companies and international brands. In Swedish Life Sciences many of the Swedish companies representing the entire health care spectrum are compiled and presented, there among Attana AB.